RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1098
Malaria parasiteP. yoelii
Genotype
DisruptedGene model (rodent): PY17X_0304500; Gene model (P.falciparum): PF3D7_0206200; Gene product: pantothenate transporter (PAT)
Transgene
Transgene not Plasmodium: eGFP
Promoter: Gene model: PYYM_0712000; Gene model (P.falciparum): Not available; Gene product: heat shock protein, putative (HSP70)
3'UTR: Gene model: Not available; Gene product: Not available
Replacement locus: Gene model: PY17X_0304500; Gene product: pantothenate transporter (PAT)
Phenotype Oocyst; Sporozoite;
Last modified: 20 July 2014, 17:32
  *RMgm-1098
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25012929
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 17XNL
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherHart RJ; Aly AS
Name Group/DepartmentDepartment of TropicalMedicine
Name InstituteTulane University
CityNewOrleans
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-1098
Principal namePypat(-)
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNo (mature) oocysts are formed
SporozoiteNo (mature) oocysts are formed. No sporozoites are formed
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of pantothenate transporter (PAT) and expresses GFP under the control of the strong and constitutive hsp70 promoter.

Protein (function)
Pantothenic acid (or vitamin B5, or when ionized as pantothenate) is a precursor of coenzyme A (CoA), which is an essential enzyme cofactor in all living organisms. CoA plays important roles in cellular metabolism and fatty acid biosynthesis. Pantothenate acquisition from extracellular sources has been shown to be essential in nearly all non-photosynthetic cells for CoA biosynthesis. Culture media lacking pantothenic acid do not allow growth of P. falciparum. Supplementation of this vitamin B5-free medium with pantothenic acid alone was sufficient to restore normal parasite growth, suggesting that pantothenic acid is an essential vitamin transported by the parasite from host plasma and is absolutely required for parasite intraerythrocytic development. Since pantothenic acid requires a specialized transporter to move across cellular membranes, the transport of this essential precursor into P. falciparum-infected erythrocytes and its subsequent metabolism into CoA are therefore essential for this parasite’s survival. All CoA biosynthesis genes have been identified in the Plasmodium genomes except the pantothenate transporter.
A conserved putative transporter gene with multiple transmembrane domains have been functionally characterized as a candidate pantothenate transporter (PAT) in P.  falciparum. PfPAT localized to the parasite plasma membrane of P. falciparum and its expression in a fen2D yeast mutant (lacking the only pantothenate transporter Fen2p) restored growth on low pantothenate concentrations and restored sensitivity to the antifungal drug, fenpropimorph, which is primarily transported into yeast cells via the Fen2 permease. Moreover, genetic studies in P. falciparum indicated that PfPAT gene is not amenable to targeted deletion by classical genetic methods and down-regulation of its expression using morpholino-based oligonucleotides resulted in parasite death. Together these data indicated that PfPAT might function as the primary pantothenate transporter of P. falciparum and its transport activity could be essential for BS development.

Phenotype
Blood stage development, gametocyte and ookinete production were similar to that of wild type parasites. No (mature) oocysts are formed. No sporozoites are formed indicating an essential role of PAT in the transition of mature ookinetes into (mature) oocysts.

Additional information

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_0304500
Gene Model P. falciparum ortholog PF3D7_0206200
Gene productpantothenate transporter
Gene product: Alternative namePAT
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1GGCCGCGGTCATGTAATGTTATAGTGTCATGCAACTAAAAAT
Additional information primer 131
Sequence Primer 2TCCGGATCCCGCTTACCTGTTTTGGGTATAGGAATCGGCATTCAT
Additional information primer 232
Sequence Primer 3TGCCAAGCTTTCAAAATAGGATAATAATAGATACTTTTAGAAT
Additional information primer 333
Sequence Primer 4TCCGGTACCTATATAGATATACATATTACTAAAAATGCAGTC
Additional information primer 434
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameeGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PYYM_0712000
Gene Model P. falciparum ortholog Not available
Gene productheat shock protein, putative
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PY17X_0304500
Gene productpantothenate transporter
Gene product: Alternative namePAT
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4